Pharmacy Store Expansion and Response to Community Healthcare Needs
First written in FY2016. 21 of 33 entries say "Advanced", first in FY2017-Q1. Latest entry: FY2027-H1.
2 other companies' latest entry also says "Advanced".
- FY2027-H1AdvancedAnnual report
「In the dispensing pharmacy business, which operated 162 stores, including 1 store acquired through M&A during the period,」
The number of pharmacies increased from 161 in the previous disclosure to 162, including 1 store acquired through M&A. - FY2026AdvancedAnnual report
「In the pharmacy business, which had a total of 161 stores following the opening of 5 stores and closure of 2 during the current period,」
The company opened 5 pharmacies and closed 2 during the current period, increasing the number of stores from 154 in the previous period to 161. - FY2026-H1AdvancedAnnual report
「In the pharmacy business, which operated 159 stores following the opening of 2 stores and closure of 1 during the current period, prescription revenue per prescription increased, in addition to」
The number of pharmacies increased from 158 at the end of the previous fiscal year to 159 after the company opened 2 stores and closed 1. The company also reported higher prescription revenue per prescription and a contribution to revenue from the drugstore-related business of mik japan. - FY2025-H1AdvancedAnnual report
「The business operated 158 stores after opening 4 stores during the period.」
The company opened 4 pharmacies during the interim period, increasing the number of stores from 154 at the end of the previous fiscal year to 158. - FY2024-Q3AdvancedAnnual report
「The business operated 154 stores after opening 5 stores during the period.」
The company opened 5 pharmacies during the current period, increasing the number of stores from 152 in the previous quarter to 154. Revenue increased due to the effects of new stores and higher prescription revenue per prescription. - FY2024-Q2AdvancedAnnual report
「The business operated 152 stores after opening 3 stores during the period.」
The company opened 3 pharmacies during the current period, increasing the number of stores from 149 in the previous quarter to 152. Revenue increased due to an increase in the number of prescriptions from the effects of new stores and higher prescription revenue per prescription. - FY2024-Q1AdvancedAnnual report
「The business operated 150 stores after opening 1 store during the period.」
The company opened 1 pharmacy during the current period, increasing the number of stores from 149 at the end of the previous period to 150. Pharmacy services reported higher revenue year on year, due partly to an increase in prescriptions at existing stores and higher prescription revenue per prescription. - FY2023-Q3AdvancedAnnual report
「During the fiscal year, the company expanded its operations to 149 locations by opening 4 locations, including 2 acquired through M&A.」
The company opened 4 pharmacies, 2 of which were acquired through M&A, bringing the number of stores to 149. This was an increase of 4 stores from 145 at the end of the previous period. - FY2023-Q2RestatedAnnual report
「The business operated 147 stores after opening 2 stores during the period.」
The company opened 2 pharmacies and operates 147 stores. The number of stores was unchanged from the previous quarter, and the company continued to report store expansion and an increase in the number of prescriptions due to the effects of new stores. - FY2023-Q1AdvancedAnnual report
「The business operated 147 stores after opening 2 stores during the period.」
The company opened 2 pharmacies, increasing the number of stores from 145 at the end of the previous period to 147. The number of prescriptions increased due to the effects of new stores, resulting in higher revenue, while operating profit declined year on year due partly to differences in the timing of drug purchases. - FY2022AdvancedAnnual report
「The business operated 145 stores after opening 11 stores and closing 4 during the period.」
The number of pharmacies increased from 138 stores at the end of the previous period to 145 after the company opened 11 stores and closed 4. Pharmacy services reported higher revenue and profit due to the recovery in the number of prescriptions, the strengthening of the primary-care pharmacy function and higher unit prices for technical fees. - FY2022-Q3AdvancedAnnual report
「The company operated 142 stores following the opening of 8 stores and closure of 4 during the current period. In addition to the effects of new stores, including the 7 stores opened in the previous period, the number of prescriptions increased as recovery from the decline in prescription patients caused by patients refraining from seeking medical care showed signs of emerging. In addition, the unit price of technical fees increased due partly to the strengthening of the community-based primary-care pharmacy function, resulting in higher revenue and profit year on year.」
The number of pharmacies increased from 141 stores in the previous quarter to 142. In addition to opening 8 stores and closing 4 during the current period, the company reported higher revenue and profit due to the recovery in the number of prescriptions and higher unit prices for technical fees from strengthening the primary-care pharmacy function. - FY2022-Q2AdvancedAnnual report
「The company operated 141 stores following the opening of 5 stores and closure of 2 during the current period. In addition to the effects of new stores, including the 7 stores opened in the previous period, the number of prescriptions increased as recovery from the decline in prescription patients caused by patients refraining from seeking medical care gradually emerged. In addition, the unit price of technical fees increased due partly to the strengthening of the community-based primary-care pharmacy function, resulting in higher revenue and profit year on year.」
The number of pharmacies increased from 140 stores in the previous quarter to 141. In addition to opening 5 stores and closing 2 during the current period, the company reported higher revenue and profit due to the recovery in the number of prescriptions, the strengthening of the primary-care pharmacy function and higher unit prices for technical fees. - FY2022-Q1AdvancedAnnual report
「The company operated 140 stores following the opening of 2 stores during the current period. In addition to the effects of new stores, including the 7 stores opened in the previous period, the number of prescriptions increased as recovery from the decline in prescription patients caused by patients refraining from seeking medical care gradually emerged. In addition, the unit price of technical fees increased due partly to the strengthening of the community-based primary-care pharmacy function, resulting in higher revenue and profit year on year.」
The company opened 2 pharmacies during the current period, increasing the number of stores from 138 at the end of the previous period to 140. Pharmacy services reported higher revenue and profit due to the recovery in the number of prescriptions, the strengthening of the primary-care pharmacy function and higher unit prices for technical fees. - FY2021RestatedAnnual report
「The business operated 138 stores after opening 7 stores and closing 2 stores during the period.」
The number of pharmacies reached 138 after the company opened 7 stores and closed 2. The number of stores was unchanged from the third quarter, and the company continued to expand its store network. - FY2021-Q3AdvancedAnnual report
「The business operated 138 stores after opening 7 stores and closing 2 stores during the period.」
The number of pharmacies increased from 133 stores in the previous quarter to 138. The company specifically disclosed that it opened 7 stores and closed 2 stores during the current period. - FY2021-Q2AdvancedAnnual report
「The business operated 137 stores after opening 5 stores and closing 1 store during the period.」
The number of pharmacies increased from 134 stores in the previous quarter to 137. The company specifically disclosed that it opened 5 stores and closed 1 store during the current period. The number of prescriptions declined due to the spread of COVID-19, and pharmacy services reported lower revenue and profit. - FY2021-Q1AdvancedAnnual report
「The company operated 134 stores following the opening of 1 store during the current period. Although prescription revenue per prescription increased as the spread of COVID-19 led to an increase in long-term prescriptions, the number of prescriptions declined due to patients refraining from seeking medical care and medical institutions reducing outpatient services, resulting in lower revenue year on year.」
The company opened 1 pharmacy during the current period, increasing the number of stores from 133 to 134. However, the decrease in the number of prescriptions resulting from patients refraining from seeking medical care and reduced outpatient services exceeded the increase in revenue per prescription from long-term prescriptions. - FY2020-Q3AdvancedAnnual report
「The business operated 133 stores. The effects of new stores opened during the period and in the previous period, together with higher prescription prices, resulted in higher revenue and profit year on year.」
The number of pharmacies increased from 131 stores in the previous quarterly report to 133. The company also reported higher revenue and profit due to the effects of new stores opened during the current and previous periods and higher prescription revenue per prescription. - FY2020-Q2AdvancedAnnual report
「The business operated 131 stores. The effects of new stores opened during the period and in the previous period, together with higher prescription prices, resulted in higher revenue and profit year on year.」
The number of pharmacies increased from 130 stores in the previous quarterly report to 131. The company also reported higher revenue and profit due to the effects of new stores opened during the current and previous periods and higher prescription revenue per prescription. - FY2020-Q1AdvancedAnnual report
「The business operated 130 stores. The effects of new stores opened during the period and in the previous period, together with higher prescription prices, resulted in higher revenue and profit year on year.」
The number of pharmacies increased from 124 stores in the immediately preceding quarterly report to 130. The company also reported higher revenue and profit due to the effects of new stores opened during the current and previous periods and higher prescription revenue per prescription. - FY2019-Q3RestatedAnnual report
「Although the opening of new stores during the current and previous periods contributed to the rollout of 124 stores, revenue and profit declined year on year due in part to the impact of medical fee revisions.」
The company operated 124 pharmacies, unchanged from the previous quarter, and reported the effects of new stores. However, revenue and profit declined due partly to the revision of medical service fees. - FY2019-Q2RestatedAnnual report
「Although the opening of new stores during the current and previous periods contributed to the rollout of 124 stores, revenue and profit declined year on year due in part to the impact of medical fee revisions.」
The company operated 124 pharmacies, unchanged from the previous quarter, and reported the effects of new stores. However, revenue and profit declined due partly to the revision of medical service fees. - FY2019-Q1Decrease in the reported number of storesAnnual report
「The business operated 123 stores. Although new stores opened during the period and in the previous period contributed, revenue and profit declined year on year due to the impact of the revision of medical service fees and other factors.」
The number of pharmacies decreased from 124 stores in both the previous quarter and the previous fiscal year to 123. Although the original text does not state the reason for the decrease, it also cites the effects of new stores opened during the current and previous periods. - FY2018Decrease in the reported number of storesAnnual report
「The business operated 122 stores. In addition to an increase in prescriptions received due to the effects of new stores opened during the period and in the previous period, higher prescription prices resulted in higher revenue year on year.」
The current annual report states 122 stores, down from 124 stores in the previous third-quarter report and the previous annual report. The effects of new stores and higher revenue continue to be reported, but the original text does not state the reason for the decrease in the number of stores. - FY2018-Q3RestatedAnnual report
「The business operated 124 stores. Prescription volumes increased due to the effects of new stores opened during the period and in the previous period, resulting in higher revenue year on year.」
The company operated 124 pharmacies, unchanged from the previous quarter, and continued to report an increase in the number of prescriptions received and higher revenue due to the effects of new stores opened during the current and previous periods. - FY2018-Q2RestatedAnnual report
「The business operated 124 stores. Prescription volumes increased due to the effects of new stores opened in the previous period and other factors, resulting in higher revenue year on year.」
The company operated 124 pharmacies, unchanged from the previous quarter. It continued to report an increase in the number of prescriptions received and higher revenue due to the effects of new stores opened in the previous period. - FY2018-Q1RestatedAnnual report
「The business operated 124 stores. Prescription volumes increased due to the effects of new stores opened in the previous period and other factors, resulting in higher revenue year on year.」
The number of pharmacies at the end of the period was 124, with no increase from the end of the previous period. The company reported an increase in the number of prescriptions received and higher revenue due to the effects of new stores opened in the previous period and other factors. - FY2017RestatedAnnual report
「The business operated 124 stores. Although the effects of 9 new stores opened during the period and 4 opened in the previous period contributed, revenue and profit declined year on year due to the negative impact of the revision of medical service fees and other factors.」
The number of pharmacies at the end of the period was 124, with no increase from the immediately preceding third-quarter report. For the full year, the company reported the effects of opening 9 stores during the current period. - FY2017-Q3AdvancedAnnual report
「The business expanded to 124 stores. Although new store openings contributed 8 stores in the current fiscal year and 4 in the previous fiscal year, revenue and profits decreased year on year due to the negative impact of revisions to medical service fees and other factors.」
The number of pharmacies increased from 120 stores in the previous quarter to 124, and the company reported the effects of opening 8 stores during the current period. However, revenue and profit declined due partly to the revision of medical service fees. - FY2017-Q2Decrease in the reported number of storesAnnual report
「Although the opening of 4 stores during the current period and 4 stores during the previous period contributed to the rollout of 120 stores, revenue and profit declined year on year due in part to the negative impact of the medical fee revision.」
The current quarterly report states 120 stores, down from 122 stores in the previous quarterly report. Although the original text does not state the cause or significance, it also cites the effects of opening 4 stores during both the current and previous periods. - FY2017-Q1AdvancedAnnual report
「The pharmacy business expanded to 122 stores, with revenue increasing year on year due to the contribution from 4 new stores opened during the period and 4 opened in the previous period.」
The number of pharmacies increased from 119 stores in the previous fiscal year to 122, and the company reported higher revenue from the effects of opening 4 stores during the current period. - FY2016First statedAnnual report
「The business expanded to 119 stores, and revenue increased year on year due to the effects of opening 4 stores during the current period and 8 stores in the previous period, as well as higher prescription revenue per prescription.」
The company is opening new pharmacies and operates 119 stores in the Tokai, Hokuriku, Kansai and Shikoku regions.